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 2 
Abstract 21 
Staphylococcus aureus is one of the main etiological agents of mastitis in different 22 
mammalian species. At present, it is unknown if strains isolated from human mastitis 23 
cases share phenotypic properties and genetic background with those obtained from 24 
animal mastitis cases. Therefore, the objective of this study was to characterize S. 25 
aureus strains isolated from women with lactational mastitis and to compare them with 26 
strains responsible for bovine mastitis and non-infectious strains. All the strains were 27 
genotyped by both Pulsed Field Gel Electrophoresis (PFGE) and Multilocus sequence 28 
typing (MLST) and submitted to a characterization scheme that included diverse assays 29 
related to pathogenic potential and antibiotic resistance. Apart from siderophore 30 
production, no significant association was observed between the strains from bovine 31 
and human mastitis. Statistical differences between human- and bovine-mastitis 32 
associated strains were detected for some traits and virulence determinants; such as the 33 
presence of prophages and cna and hlb genes, which were more frequently found within 34 
the bovine group. On the contrary, resistance to penicillin was significantly higher 35 
among strains isolated from human lactational mastitis, probably related to the common 36 
presence of the blaZ gene. A high genetic diversity was found among the strains 37 
involved in mastitis in breastfeeding women. 38 
39 
 3 
Introduction 40 
Mastitis is the inflammation of the mammary gland mainly due to a bacterial 41 
infection and it is characterized by a variety of local and systemic symptoms. In 42 
Veterinary Medicine, the number of studies dealing with the distribution and 43 
characterization of the bacterial species involved in mastitis is considerable (Vasudevan 44 
et al., 2003; Fueyo et al., 2005; Smith et al., 2005; Kozytska et al., 2010). In contrast, 45 
scientific articles on the bacteria causing infectious mastitis in lactating women are 46 
scarce and most are, at least, 10 years old (Foxman et al., 2002). However, this 47 
condition is relatively common since its incidence oscillates between 5 and 33% of 48 
lactating mothers (WHO, 2000; Foxman et al., 2002). Staphylococcus aureus (Thomsen 49 
et al., 1983; Riordan & Nichols, 1990) and coagulase-negative staphylococci (Delgado 50 
et al., 2009) are among the most common etiological agents although, unfortunately, 51 
microbiological analysis of human milk and characterization of the strains involved in 52 
human mastitis are exceptional. 53 
S. aureus can express a wide array of potential virulence factors, including surface 54 
proteins that promote adherence to damaged tissue, and/or exotoxins and enzymes than 55 
can cause a variety of infections in skin and soft tissues, including intramammary 56 
mastitis (Iwatsuki et al., 2006). Some evidence suggests that biofilm formation can be a 57 
virulence factor associated with S. aureus mastitis (Vasudevan et al., 2003). 58 
Furthermore, this microorganism can display resistance to several relevant antibiotics, 59 
making its eradication difficult (Casey et al., 2007). 60 
Common genotypes of S. aureus causing mastitis in different ruminants have been 61 
described suggesting potential tissue specificity (Mørk et al., 2005; Aires de Sousa et al., 62 
2007). However, different genetic clusters and lineages among strains isolated from 63 
samples of human and bovine origin have been reported (Zadoks et al., 2000; van 64 
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Leeuwen et al., 2005), which point to the concept of host specialization (Herron-Olson 65 
et al., 2007; Sung et al., 2008). In humans, most infections caused by S. aureus seem to 66 
derive by own carriage strains (Wertheim et al., 2005). The potential virulence factors 67 
possessed by the S. aureus strains associated with human mastitis remain still 68 
undescribed. The objective of this work was to assess and compare the presence of 69 
pathogenic traits among a number of strains of S. aureus isolated from both women and 70 
cows suffering lactational mastitis, alongside some non-infectious strains, by a variety 71 
of geno- and phenotypic assays. 72 
 73 
Material and methods 74 
S. aureus strains and growth conditions  75 
Twenty strains of S. aureus isolated from cases of infectious mastitis were included 76 
in this study. Among them, 10 were isolated from breast milk of women suffering 77 
mastitis (OD111, S3B, ACLI1, S1LI12, DH3a, DI2e, BALD1, O2LI2, Z2LD1 and 78 
AXLI12; Delgado et al., 2008) while the remaining 10 were isolated from milk of dairy 79 
cows with clinical mastitis in Asturias, Spain (SA1, SA3, SA4, SA5, SA8, SA10, SA11, 80 
SA14, SA15 and SA16; García et al., 2009). In addition, 10 strains with a non-clinical 81 
origin were also included for comparative purposes: five from breast milk of healthy 82 
women (LC001, LG5081, LX153b, L1741 and L1744; Jiménez et al., 2008) and five 83 
from bulk tank milk (GDC3, GDC6, AC11, JFL2 and GRA16; García et al., 2009). Five 84 
S. aureus strains (CECT 435, CECT 957, CECT 976, CECT 4013, and CECT 4439) 85 
from the Spanish Culture Collection were used as controls in the different assays. The 86 
isolates were routinely grown in liquid and agarized Brain Heart Infusion (Oxoid, 87 
Basingstoke, UK) at 37 C for 24 h and their identity was confirmed on the basis of 88 
different microbiological and biochemical tests (shape, Gram-staining, catalase and 89 
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coagulase activities) and PCR sequencing of tuf (Martineau et al., 2001), and 16S rRNA 90 
genes using primers pbl16 (5´-AGAGTTTGATCCTGGCTCA-3´) and mlb16 (5´-91 
GGCTGCTGGCACGTAGTTAG-3´) (Kullen et al., 2000). 92 
 93 
Genotyping of the isolates by Pulsed field gel electrophoresis (PFGE) and 94 
Multilocus sequence typing (MLST) 95 
All isolates were submitted to PFGE genotyping according to the protocol of 96 
Murchan et al. (2003). Chromosomal DNA was digested with the endonuclease SmaI 97 
(New England Biolabs, Ipswich, USA) at 37 ºC for 16 h. Then, electrophoresis was 98 
carried out in a CHEF DR-III apparatus (Bio-Rad Laboratories, Hercules, USA) for 23 99 
h at 14 °C at 6 V cm
-1
 with pulses from 5 to 50 s. A standard pattern (Lambda Ladder 100 
PFG Marker, New England Biolabs) was included in the gels to allow comparison of 101 
the digitally normalized PFGE profiles. Gels were analyzed with Phoretix 5.0 software 102 
(Nonlinear Dynamics Ltd., United Kingdom) using Dice's coefficient to perform the 103 
cluster analysis of the PFGE patterns. 104 
MLST was carried out as previously described by Enright et al. (2000). The method 105 
involves the amplification by PCR of seven housekeeping genes (arcC, aroE, glpF, gmk, 106 
pta, tpi and yqiL) following sequencing, and each unique sequence defines an allele. 107 
Bacterial genomic DNA used for the PCR reactions was obtained from pure cultures 108 
with the DNeasy tissue kit (QIAgen, Hilden, Germany). The resulting sequences were 109 
trimmed, aligned and compared to the allele sequences in the S. aureus MLST database 110 
(http://saureus.mlst.net/), and each allelic profile was assigned to a sequence type (ST). 111 
All of them were submitted to the database and registered under identity numbers 3193 112 
to 3220. The STs were clustered into clonal complexes (CCs) by using the eBURST 113 
algorithm (www.eburst.mlst.net).  114 
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 115 
Detection of genes encoding toxins, adhesins and other virulence determinants 116 
The presence of different toxins, adhesins and other virulence factors, including 117 
some antibiotic resistance genes, was screened by PCR using the primers described in 118 
Table 1. For the detection of the four hemolysin genes (hla, hlb, hlg, hld) a multiplex 119 
PCR method was developed with the following conditions: 1 cycle of 95 C for 5 min, 120 
30 cycles of 95 C for 1 min, 58 C for 1 min, and 72 C for 2 min, and a final 121 
extension of 72 C for 10 min. The genes encoding four adhesins (fnbA, clfa, sdrE, ebpS) 122 
were detected by multiplex PCR. The PCR program consisted of 1 cycle of 95 C for 5 123 
min, 30 cycles of 95 C for 1 min, 50 C for 1 min, and 72 C for 2 min, and a final 124 
extension of 72 C for 10 min. Each multiplex PCR reaction mixture consisted of 3 mM 125 
MgCl2, 1.5X Taq buffer, 4 mM each dNTP, 2.5 U EcoTaq polymerase (Ecogen, 126 
Barcelona, Spain), 10 M of each primer and 1.5 l of purified DNA. Single PCR 127 
reactions were used for screening the rest of the genes with standard concentrations of 128 
the components in the mixtures and the conditions originally described (Table 1). The 129 
use of different annealing temperatures in these reactions is specified in Table 1. 130 
 131 
Determination of minimal inhibitory concentrations (MICs) to antibiotics  132 
The determination of the MICs to several antibiotics commonly used against 133 
staphylococcal infections was performed by a microdilution method using the Sensititre 134 
plates Staenc1F (Trek Diagnostic Systems, Cleveland, USA) following the 135 
manufacturer’s instructions. The antibiotics analyzed were: penicillin, ampicillin, 136 
amoxycillin-clavulanic acid, teicoplanin, chloramphenicol, erythromycin, mupirocin, 137 
streptomycin, gentamicin, clindamycin, oxacillin, ciprofloxacin, fosfomycin, imipenem, 138 
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nitrofurantoin, trimethoprim-sufamethoxazole, tetracycline, vancomycin, linezolid, 139 
quinupristin-dalfopriscin, and rifampin. 140 
 141 
Phenotypic assays 142 
a) Determination of hemolytic activity. Hemolytic activity was assayed on 143 
Columbia agar plates supplemented with 5% sheep blood (bioMérieux, Marcy l'Etoile, 144 
France) following the procedure of Freney et al. (1999). After an incubation of 72 h at 145 
37 C, plates were analyzed and the strains were considered hemolytic if complete lysis 146 
of the red blood cells surrounding the colony was observed (halo ~1.5 mm). 147 
b) Slime production. The ability of the isolates to form slime was assessed using 148 
the Congo Red Agar assay (Freeman et al., 1989). The plates were incubated at 37 C 149 
for 24 h followed by additional storage at room temperature 24 h. Isolates displaying 150 
rough black colonies were considered as slime producers while those showing red 151 
colonies were negative. 152 
c) Biofilm formation ability. Biofilm formation was assayed using a microtiter 153 
plate assay as described Vasudevan et al. (2003) with some modifications. Strains were 154 
grown in Brain Heart Infusion and the cultures were diluted 1:200 in Tryptic Soy Broth 155 
(Oxoid) supplemented with 0.25% glucose. Aliquots of 200 l of each dilution were 156 
placed into 96-well “U” bottom polystyrene microtiter plates and incubated for 18 h at 157 
37 °C. The wells were washed three times with 300 l of sterile phosphate-buffered 158 
saline (pH 7.2) and let dried at room temperature. Afterwards, 25 l of a 1%crystal 159 
violet solution was added to the wells for biofilm staining and the plates were incubated 160 
for 15 min at room temperature. Microtiter plates were washed by fully immersing in 161 
water and allowed to dry in inverted position. Bounded crystal violet was solubilized in 162 
200 l of ethanol (95% v/v), and 125 l were transferred to another plate to measure the 163 
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optical density (OD) of each well at 570 nm using a MicroELISA Auto Reader 164 
(Labsystems, Helsinki, Finland). Each strain was tested in triplicate and a known 165 
biofilm-producer strain (S. aureus CECT 4013) was included as a positive control in all 166 
assays. The biofilm assays were performed on duplicate. 167 
d) Lysogeny determination. The presence of resident prophages in the S. aureus 168 
strains was checked after mitomycin C induction. Mid-exponential phase cultures were 169 
obtained for each strain and mitomycin C (Sigma-Aldrich, St. Louis, USA) was added 170 
at a concentration of 0.5 µg ml
-1
. Samples were incubated for 4 h at 37 ºC and 171 
supernatants filtered and subjected to plaque assay. Each supernatant was tested against 172 
all strains. Aliquots (0.1 ml) of stationary-phase host cultures were mixed with 173 
appropriate dilutions of individual phage suspensions in 5 ml of molten 2xTY top agar 174 
(0.7% agar) and the mixture was poured on 2xTY agar plates (Sambrook et al., 1989). 175 
e) Siderophore production. The siderophore production in liquid culture was 176 
performed following the methodology previously used by Massonet et al. (2006) with 177 
some modifications. For the growth of the strains, the RPMI 1640 medium (Sigma) was 178 
used. Iron was removed from the RPMI medium by overnight batch incubation with 6% 179 
(w/v) sterile Chelex 100 (Sigma) at room temperature. To avoid the reduction in the 180 
calcium and magnesium levels by the chelating effect of Chelex, the medium was 181 
afterwards enriched with filter sterilized solutions of CaCl2 (0.07 mM) and MgSO4 (0.7 182 
mM). S. aureus strains were inoculated in the iron-depleted medium and incubated for 183 
24 h at 37 °C in an orbital shaker. Then, the strains were subcultured (1%) in the same 184 
medium and incubated under the same conditions for 48 h. Cultures were centrifuged at 185 
16,000 × g for 5 min and the supernatants were assayed for siderophore production. 186 
Siderophore production was measured with the Chrome Azurol S liquid assay as 187 
described by Schwyn and Neilands (1987). Briefly, 500 l of supernatant were mixed 188 
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with 500 l of Chrome Azurol S solution and 10 l of shuttle solution (0.2 M 5´-189 
sulfosalicylic acid) were added to the mixture. After 15 min of incubation at room 190 
temperature the absorbance at 630 nm was measured. The percentage of siderophore 191 
units was calculated as follows: [(Ab-As)/Ab] x 100, being Ab the absorbance of the 192 
non-inoculated medium and As the absorbance of the samples. 193 
 194 
Statistical analysis 195 
The distribution of putative virulence genes, antibiotic resistance, hemolysis, slime 196 
production and lysogeny among the S. aureus strains from different hosts (human and 197 
bovine) with mastitic infection and/or from mastitis-associated and non-infectious 198 
strains was compared using two-tailed Fisher's exact test. The non-parametric Kruskal 199 
Wallis test was used to compare the biofilm forming ability between strains isolated 200 
from bovine and human mastitis cases and the siderophore production observed in 201 
mastitis and non-infectious strains. Differences between groups were considered 202 
statistically significant if P values were  0.05. Statistical analysis was performed with 203 
the SPSS statistical package (SPSS Inc., Chicago, USA).  204 
 205 
Results and Discussion 206 
Genetic diversity. Twenty strains of S. aureus from mastitis (10 from human and 207 
10 from bovine cases) and 10 strains that were not involved in infections (five from 208 
breast milk of healthy women and five from bulk tank milk) were included in the study. 209 
Except for GRA16 and AC11 isolates from bulk tank milk, all the strains could be 210 
individually distinguished by PFGE genotyping since each strain generated a different 211 
band pattern. Three main clusters were observed in the dendrogram obtained by 212 
computer assisted analysis (Fig. 1). Clustering of the strains was not apparently based 213 
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on the host or pathogenic origin. Strains from human mastitis were distributed along the 214 
three clusters and showed diverse genotypes. On the contrary, most of the isolates from 215 
bovine mastitis (8 out of 10) showed closely-related pulsotypes and grouped together in 216 
the same cluster. The existence of common or similar genotypes among S. aureus 217 
isolated from bovine mastitis has been previously reported and could reflect a long-term 218 
persistence into the bovine mammary gland (Anderson & Lyman, 2006). The strains 219 
were also typed by MLST analysis, and the results were in accordance with those 220 
obtained by PFGE (Fig. 1) even though different pulsotypes were observed within 221 
strains grouped in the same ST. Seven out the 10 isolates causing bovine mastitis 222 
grouped into ST97/ST352-CC97 and two strains were related to ST151. These lineages 223 
are rather prevalent among bovine mastitis isolates from different countries (Smith et al., 224 
2005; Herron-Olson et al., 2007; Rabello et al., 2007; Sung et al., 2008) and seem to be 225 
adapted, not only to the mammary gland, but also to the bovine environment. This 226 
adaptation would explain their presence also among the strains obtained from bulk tank 227 
milk. Human mastitis strains presented higher diversity than the bovine ones belonging 228 
up to 7 different CCs, including the newly described ST1598-CC154 and the singleton 229 
ST1597. Some strains of human origin, including those isolated from healthy women, 230 
belong to CC5 and CC30. These clonal complexes have previously been related to S. 231 
aureus infections in humans but were also associated to asymptomatic human carriers 232 
(Wertheim et al., 2005; Rabello et al., 2007; Sakwinska et al., 2009). This could 233 
indicate that some S. aureus mastitis infections in breastfeeding women may derive by 234 
own carriage strains and host predisposal factors might be also important in the 235 
development of lactational mastitis. 236 
 237 
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Presence of potential virulence genes. Multiple properties of S. aureus contribute 238 
to its virulence. In this study, the presence of 18 genes encoding a variety of potential 239 
virulence factors was determined by PCR (Fig. 2), and the results are shown in Table 2. 240 
Statistical analysis was only applied to 11 out of the 18 genes, since hla, hld, fnbA, clfA, 241 
icaA were present in all the strains and pvl-S/F, se-adej were absent in all of them. 242 
Significant differences between strains isolated from human and bovine cases of 243 
infectious mastitis were observed for two genes; cna and hlb genes, encoding a collagen 244 
adhesin and the β-hemolysin, respectively, that were more common in the bovine than 245 
in the human group (10/5 strains, Fisher's exact test P = 0.033, for cna gene and 8/1 246 
strains, Fisher's exact test P = 0.006, for hlb gene). No significant differences were 247 
observed in the rest of tested genes, even though the occurrence of blaZ gene (encoding 248 
resistance to β-lactams antibiotics) was higher among the human strains (9 versus 4 249 
strains, P = 0.057). Pyrogenic toxin superantigens genes such as those encoding the 250 
toxic shock syndrome toxin (tst) and the exfoliative toxin (eta) were found in a small 251 
number of strains independently of the source, while the pvl-M/F gene, implicated in the 252 
damage of host defense cell membranes, was present in four bovine strains. The 253 
important role of these toxins in bovine mastitis has been previously reported and the 254 
presence of the leukocidin M/F variant has been described as characteristic of bovine S. 255 
aureus strains (Fueyo et al., 2005; Yamada et al., 2005; Monecke et al., 2007). When 256 
bacterial strains from clinical and non clinical origin were compared, presence of sirB 257 
gene (encoding an iron-siderophore transporter) was found to be associated to strains 258 
isolated from cases of infectious mastitis independently of their human or bovine origin 259 
(Fisher's exact test, P = 0.008). 260 
 261 
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Antibiotic resistance. Regardless of their origin, all the strains were sensitive to 262 
gentamicin (2 g ml-1), tetracycline (4 g ml-1), nitrofurantoin (32 g ml-1), 263 
mupirocin (4 g ml-1), streptomycin (1,000 g ml-1), clindamycin (0.5 g ml-1), 264 
imipenem (0.12 g ml-1), rifampin (1 g ml-1), trimethoprim/sulfamethoxazole 265 
(1/38 g ml-1), fosfomycin (16 g ml-1) and teicoplanin (0.5 g ml-1). Most of the 266 
strains from cow’s bulk tank milk and healthy women were susceptible to the lowest 267 
concentration of most antibiotics (data not shown). All strains recovered from mastitis 268 
infections were susceptible to oxacillin, ciprofloxacin, vancomycin and 269 
quinupristin/dalfopristin according to the breakpoints established by the Clinical and 270 
Laboratory Standards Institute (CLSI, 2010). In general, strains involved in human 271 
mastitis showed higher MICs than isolates from bovine mastitis, with intermediate 272 
resistances observed for some antibiotics (such as chloramphenicol and erythromycin) 273 
among the strains involved in human mastitis (Table 3). A significant difference was 274 
detected for penicillin resistance between isolates from human and bovine cases of 275 
infectious mastitis (Fisher's exact test, P = 0.020). Three out of the 10 strains recovered 276 
from bovine mastitis were ampicillin resistant, in contrast to seven out of 10 obtained 277 
from human mastitic milk, even though the difference was not statistically significant 278 
(Fisher's exact test, P = 0.101). In concordance with these results, the mecA gene was 279 
not detected among the mastitis-related strains and the presence of the blaZ gene was 280 
higher among the human isolates from mastitic milk (Fisher's exact test, P = 0.057). 281 
This enhanced antibiotic resistance of human S. aureus has been previously described 282 
(Reinoso et al., 2008) and might be a consequence of higher antibiotic pressure in 283 
human hosts. 284 
 285 
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Hemolysis. All the non-infectious strains displayed a non hemolytic behaviour on 286 
sheep blood agar plates. In contrast, most of the isolates from bovine mastitis cases 287 
(8/10) showed a complete lysis of the red blood cells surrounding the colony causing a 288 
clearing of the blood from the medium, while only four of the strains from human 289 
mastitis presented this type of hemolysis (Table 4). However, this difference was not 290 
statistically significant (Fisher's exact test, P = 0.170). Strains of S. aureus from bovine 291 
milk typically produce -hemolysin (Larsen et al., 2002; Monecke et al., 2007), while 292 
many human isolates have -hemolysin-converting bacteriophages inserted in the hlb 293 
gene (van Wamel et al., 2006). Although -, -, and -hemolysins are relevant in 294 
several infections caused by S. aureus, the pathogenic significance of such toxins in 295 
human disease has not yet been fully established (Iwatsuki et al., 2006). Some authors 296 
have reported the ubiquitous nature of some of these hemolysins (like the α-hemolysin 297 
encoded by hla gene) regardless of the strain source (Peacock et al., 2002). 298 
 299 
Slime and biofilm production. Slime production was a relatively frequent 300 
phenotype among the mastitis-associated strains, with 12 out of the 20 strains positive 301 
in the Congo Red Agar assay (Table 4) in contrast with only three out 10 non-infectious 302 
strains. However this difference was not statistically different (Fisher's exact test, P = 303 
0.245). In parallel, the potential for biofilm production was determined by a quantitative 304 
assay using microtiter plates and the results are shown in Table 4. Globally, the 305 
adhesion to polystyrene plates was low when compared with a positive control 306 
(OD5701) in spite of the fact that all of them contained the gene icaA. There was not a 307 
statistically significant difference in the ability to form biofilm in vitro between the 308 
strains associated to bovine and human mastitis (Kruskal Wallis test, P = 0.070). 309 
Biofilm formation has been described in many cases of mastitis caused by S. aureus 310 
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(Melchior et al., 2006; Oliveira et al., 2006) but the phenotypic expression of this 311 
property can be influenced by numerous factors such as the method, or the growth 312 
media and conditions used in the assay. Discrepancies between slime production, 313 
biofilm formation in vitro, and the presence of the ica gene have been previously 314 
reported in bovine S. aureus (Vasudevan et al., 2003).  315 
 316 
Presence of prophages. The incidence of lysogenic strains was investigated since 317 
many genes associated with virulence factors in S. aureus can be encoded by mobile 318 
genetic elements such as bacteriophages. Lysogeny was observed only in two of the 10 319 
strains isolated from human milk supplied by women with mastitis and in one strain 320 
from milk of a healthy woman (Table 4). In contrast, phages were detected in most 321 
strains from bovine origin, with the exception of strain SA1 isolated from bovine 322 
mastitis and strain GDC3 from bulk tank milk. Globally, lysogeny was associated more 323 
frequently to bovine than to human mastitis-causing strains (Fisher's exact test, P = 324 
0.006). Some authors have proposed that lysogenization of a strain with phages carrying 325 
pvl genes may transform a non-virulent strain into a pathogenic one (Melles et al., 2004; 326 
Yamada et al., 2005). In this study, positive isolates for the long-known Panton-327 
Valentine leukocidin gene (pvl-S/F) were not detected but presence of the more recently 328 
described leukocidin M/F-PV like gene (pvl-M/F) was revealed in three of the lysogenic 329 
strains isolated from bovine mastitis infections. This gene was originally described on a 330 
prophage (PV-83) and has been associated frequently with mastitis-causing strains in 331 
different ruminants (Rainard et al., 2003; Yamada et al., 2005; Monecke et al., 2007),.  332 
 333 
Siderophore production. Another potential pathogenic trait investigated was the 334 
production of siderophores because the ability to acquire iron from the host by bacterial 335 
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siderophores may facilitate the establishment of infection. Different siderophores have 336 
been characterized in S. aureus including iron-uptake ABC transporters (Dale et al., 337 
2004). The production of siderophores was highly variable among the strains tested 338 
(Table 4), but it was significantly higher in the strains involved in mastitis than in the 339 
non-infectious group (Kruskal Wallis test, P = 0.039). In concordance with this result, 340 
the presence of sirB gene (encoding an iron-siderophore transporter) was also found to 341 
be associated to mastitis-causing strains (Fisher's exact test, P= 0.008). 342 
No clear association could be observed between the strains from human and bovine 343 
mastitis studied, except for siderophore production. In fact, some properties of the 344 
strains seemed to depend on their source. The human mastitis strains were characterized 345 
by a higher resistance to antibiotics, specifically to β-lactams. Although the small 346 
sample size is a clear limitation of this work, and further studies involving a larger 347 
number of strains will be required to confirm these results, this is the first time, to our 348 
knowledge, that S. aureus involved in human lactational mastitis have been examined in 349 
detail. High genetic diversity was found among these strains and two novel sequence 350 
types (ST1597 and ST1598) were registered. 351 
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Figure legends  515 
 516 
Fig. 1. Dendrogram obtained after clustering analysis of pulsed field gel electrophoresis 517 
profiles of the Staphylococcus aureus strains included in this study. Multilocus 518 
sequence typing results, including sequence types (STs) and clonal complexes (CCs), 519 
are also shown. 520 
 521 
Fig. 2. Multiplex PCR assays for the simultaneous detection of the genes encoding 522 
different hemolysins (a) and adhesins (b). (a) M1, molecular weight marker (DNA 523 
HyperLadder II, Bioline, London, UK); Lanes: 1, Staphylococcus aureus ACLI1; 2, S. 524 
aureus BALD1; 3, S. aureus SA2; 4, S. aureus SA15; 5, S. aureus LX153b. hlg gene: 525 
535 bp; hlb gene: 309 bp; hla gene: 209 bp; hld gene: 111 bp. (b) M2, molecular weight 526 
marker (DNA HyperLadder I, Bioline); Lanes: 1, S. aureus SA10; 2, S. aureus O2LI2; 3, 527 
S. aureus BALD1. clfA gene: 1,548 bp; fnbA gene: 1,226 bp; sdrE gene: 749 bp; ebpS 528 
gene: 506 bp. 529 
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Table 1. Primers and PCR conditions used in this study 1 
Gene Product Primers sequence (5'–3') Amplicon 
size 
Annealing 
temperature  
Control 
strain 
Reference 
eta Exfoliative toxin A 
Fw: GCAGGTGTTGATTTAGCATT 
Rv: AGATGTCCCTATTTTTGCTG 
100 bp 58 °C Isolate Z2LD1 van Leeuwen et al. 2005 
hla α-hemolysin 
Fw: CTGATTACTATCCAAGAAATTCGATTG 
Rv: CTTTCCAGCCTACTTTTTTATCAGT 
209 bp 58 °C
a
 CETC 976 Jarraud et al. 2002 
hlb β-hemolysin 
Fw: GTGCACTTACTGACAATAGTGC 
Rv: GTTGATGAGTAGCTACCTTCAG 
309 bp 58 °C
a
 CETC 976 Jarraud et al. 2002 
hlg γ-hemolysin 
Fw: GTCAYAGAGTCCATAATGCATTTAA 
Rv: CACCAAATGTATAGCCTAAAGTG 
535 bp 58 °C
a
 CECT 435 Jarraud et al. 2002 
hld δ-hemolysin 
Fw: AAGAATTTTTATCTTAATTAAGGAAGGAGTG 
Rv: TTAGTGAATTTGTTCACTGTGTCGA 
111 bp 58 °C
a
 CETC 976 Jarraud et al. 2002 
tst Toxic shock syndrome toxin 
Fw: AAGCCCTTTGTTGCTTGCG 
Rv: ATCGAACTTTGGCCCATACTTT 
404 bp 62 °C CETC 957 van Leeuwen et al. 2005 
pvl-S/F Panton-Valentin leukocidin 
(component S and F) 
Fw: ATCATTAGGTAAAATGTCTGGACATGATCCA 
Rv: GCATCAASTGTATTGGATAGCAAAAGC 
433 bp 65 °C CECT 435 Jarraud et al. 2002 
pvl-M/F Panton-Valentin leukocidin 
(component M and F) 
Fw: AACTTTCAATGATGTTAAACAAAATAGAG 
Rv: AAAATAGTCTCTAGCATTAGGTCC 
405 bp 57 °C CETC 957 Yamada et al. 2005 
se-adej Enterotoxins SEs 
Fw: AAAGATTTGCGAAAAAAGTGTGAATT 
Rv: TTKYRTATAAATABAWRTCAATATG 
669 bp 50 °C CECT 4439 Martín et al. 2003 
fnbA Adhesin for fibronectin 
Fw: CACAACCAGCAAATATAG 
Rv: CTGTGTGGTAATCAATGTC 
1,226 bp 50 °C
b
 CETC 976 van Leeuwen et al. 2005 
cna Adhesin for collagen 
Fw: AGTGGTTACTAATCATG 
Rv: CAGGATAGATTGGTTTA 
1,722 bp 45 °C CETC 976 van Leeuwen et al., 2005 
clfA Adhesin for fibrinogen 
Fw: GTAGGTACGTTAATCGGTT 
Rv: CTCATCAGGTTGTTCAGG 
1,548 bp 50 °C
b
 CETC 976 van Leeuwen et al. 2005 
sdrE Putative adhesin 
Fw: CAGTAAATGTGTCAAAAGA 
Rv: TTGACTACCAGCTATATC 
749 bp 50 °C
b
 CETC 976 Peacock et al. 2002 
ebpS Adhesin for elastin Fw: CAATCGATAGACACAAATTC 
Rv: CAGTTACATCATCATGTTTA 
506 bp 50 °C
b
 CETC 976 Peacock et al. 2002 
icaA Polysaccharide intercellular 
adhesin 
Fw: GATTATGTAATGTGCTTGGA 
Rv: ACTACTGCTGCGTTAATAAT 
770 bp 50 °C CETC 976 Peacock et al. 2002 
mecA Methicillin resistance 
Fw: GGTCCCATTAACTCTGAAG 
Rv: AGTTCTGCAGTACCGGATTTTGC 
163 bp 57 °C CECT 4439 Mehrotra et al. 2000 
blaZ β-lactamase 
Fw: ACTTCAACACCTGCTGCTTTC 
Rv: TGACCACTTTTATCAGCAACC 
173 bp 61 °C CETC 976 Martineau et al. 2000 
sirB Iron-siderophore transporter Fw: CAGCTACGGCTACCGAAATA 
Rv: CATTTTTGGGGGCTATTGTTGT 
399 bp 61 °C CECT 976 Dale et al. 2004 
a, b
 primers used in the same multiplex PCR reaction2 
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Table 2. Presence of putative virulence genes in the S. aureus isolates 1 
Virulence 
determinant 
Mastitis  Non-infectious  
Human 
(n=10) 
Bovine 
(n=10) 
 
P-value a 
Human 
(n=5) 
Bulk tank 
(n=5) 
 
P-value b 
Adhesins       
fnbA 10 10 - 5 5 - 
cna 5 10 0.033 3 2 0.231 
clfA 10 10 - 5 5 - 
sdrE 6 7 >0.99 2 3 0.694 
ebpS 9 9 >0.99 5 5 0.540 
Toxins       
eta 1 0 >0.99 0 0 >0.99 
hla 10 10 - 5 5 - 
hlb 1 8 0.006 2 4 0.700 
hlg 3 0 0.211 3 1 0.181 
hld 10 10 - 5 5 - 
tst 1 1 >0.99 1 1 0.584 
pvl-S/F 0 0 - 0 0 - 
pvl-M/F 0 3 0.211 0 1 >0.99 
se-adej 0 0 - 0 0 - 
Others       
icaA 10 10 - 5 5 - 
mecA 0 0 - 2 0 0.103 
blaZ 9 4 0.057 4 2 >0.99 
sirB 10 10 - 2 4 0.008 
a
 Fisher's exact test to compare the presence of the virulence determinant in strains from human and bovine 2 
mastitis infections 3 
b 
Fisher's exact test to compare the presence of the virulence determinant in mastitis isolates and non-infectious 4 
strains 5 
6 
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Table 3. Antibiotic susceptibility of S. aureus isolated from human and bovine mastitis cases 1 
according to the microbiological breakpoints (MICs) defined by the Clinical and Laboratory 2 
Standards Institute (CLSI) 3 
Antibiotic
a
 
Sample 
origin 
Number of  resistant (R), intermediate (I) and susceptible (S) strains according 
to MICs breakpoints (g ml-1) established by the CLSI (2010) 
PEN  R (≥ 0.25)b  S (≤ 0.12) 
 Human 9  1 
 Bovine 3  7 
AMP  R (≥ 0.5)  S (≤ 0.25) 
 Human 7    3 
 Bovine 3    7 
OXA  R (≥ 4)    S (≤ 2) 
 Human       10 
 Bovine       10 
CIP  R (≥ 4) I (2) S (≤ 1) 
 Human       10 
 Bovine       10 
CHL  R (≥ 32) I (16) S (≤ 8) 
 Human 1 6 3 
 Bovine 1    9 
ERY  R (≥ 8) I (1-4) S (≤ 0.5) 
 Human  4 6 
 Bovine   10 
VAN  R (≥ 16) I (4-8) S (≤ 2) 
 Human       10 
 Bovine       10 
LNZ  R (≥ 8)  S (≤ 4) 
 Human 1     9  
 Bovine      10  
Q/D  R (≥ 4) I (2) S (≤ 1) 
 Human        10  
 Bovine        10  
a
 PEN: penicillin; AMP: ampicillin; OXA: oxacillin; CIP: ciprofloxacin; CHL: chloramphenicol; ERY: 4 
erythromycin; VAN: vancomycin; LNZ: linezolid; Q/D: quinupristin/dalfopristin 5 
b
 Bold indicates significant differences in the number of resistant strains from human and bovine mastitis 6 
infections (Fisher's exact test, P = 0.020) 7 
8 
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Table 4. Phenotypic traits of the S. aureus isolates 1 
Strains 
Phenotypic traits 
Hemolysis Slime 
Biofilm 
(OD570) 
Siderophores
a 
(%) 
Prophages
c
 
Mastitis 
Human      
OD111 + + 0.962 45.4 + 
S3B + + 0.953 30.9 - 
ACLI1 - + 0.151 46.0 - 
S1LI12 - + 0.138 45.8 - 
DH3a - + 0.155 33.5 - 
DI2e + - 0.068 47.7 + 
BALD1 - - 0.115 33.8 - 
O2LI2 + + 0.797 27.5 - 
Z2LD1 - + 0.387 29.8 - 
AXLI12 - + 0.140 50.6 - 
Bovine      
SA1 + + 0.175 59.3 - 
SA3 + + 0.421 25.4 + 
SA4 + - 0.086 26.3 + 
SA5 - - 0.077 49.8 + 
SA8 - - 0.081 36.8 + 
SA10 + + 0.095 32.0 + 
SA11 + + 0.067 37.7 + 
SA14 + - 0.099 55.5 + 
SA15 + - 0.240 58.9 + 
SA16 + - 0.136 48.3 + 
 Non-infectious 
Human      
LC001 - - 0.143 34.7 - 
LG5081 - + 0.168 24.4
b
 + 
LX153b - - 0.087 31.3 - 
L1741 - - 0.169 29.2
b
 - 
L1744 - - 0.046 31.5
b
 - 
Bulk tank      
GDC3 - - 0.116 24.1
b
 - 
GDC6 - - 0.418 40.5 + 
AC11 - + 0.904 32.7 + 
JFL2 - + 0.517 28.6 + 
GRA16 - - 0.319 47.4 + 
a
 Siderophore production in mastitis strains differed significantly from non-infectious strains (Kruskal-2 
Wallis test, P =0.039) 3 
b
 No sirB gen was detected. 4 
c 
Presence of prophages in bovine mastitis strains differed significantly from human mastitis strains (Fisher's 5 
exact test, P =0.006) 6 
Strain                Origin            MLST 
BALD1 Human mastitis ST1597 
AXLI12 Human mastitis ST1598-CC154 
DH3a Human mastitis ST34-CC30  
ACLI1 Human mastitis ST45-CC45  
O2LI2  Human mastitis ST121-CC121 
Z2LD1 Human mastitis ST121-CC121  
SA14 Bovine mastitis ST97-CC97  
SA16 Bovine mastitis ST97-CC97  
SA10 Bovine mastitis ST26-CC25  
SA11 Bovine mastitis ST97-CC97   
SA15 Bovine mastitis ST97-CC97   
SA8  Bovine mastitis ST352-CC97  
SA5 Bovine mastitis ST97-CC97   
S1LI12  Human mastitis ST627-CC5  
DI2e Human mastitis ST1036-CC15 
SA3 Bovine mastitis ST97-CC97   
S3B Human mastitis ST83-CC5 
AC11 Bulk tank milk ST97-CC97   
GRA16 Bulk tank milk ST97-CC97  
OD11 Human mastitis ST8-CC8  
GDC6 Bulk tank milk ST151-CC151  
GDC3 Bulk tank milk ST30-CC30  
SA1 Bovine mastitis ST151-CC151  
SA4  Bovine mastitis ST151-CC151  
JFL2  Bulk tank milk ST1-CC15  
LC001 Human milk ST83-CC5  
LX153b  Human milk ST5-CC5 
LG5081  Human milk ST34-CC30 
L1741  Human milk ST34-CC30 
L1744 Human milk ST34-CC30  
(a) 
M1 1 2 3 4 5 
100 bp 
200 bp 
300 bp 
500 bp 
1,000 bp 
(b) 
M2 1 2 3 
400 bp 
600 bp 
800 bp 
1,500 bp 
